Daxor Stock Quote DXR - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

9.80

Bid

9.41

Ask

14.00

Volume

5,056

9.51 Day's Range 9.95

7.11 52 Week Range 13.30

Market Cap

41.123M

Previous Close

9.8805

Open

9.71

Last Trade

9.75

Last Trade Time

16:00:00

Financial Volume

$ 49,234

VWAP

9.7376

Average Volume (3m)

2,831

Shares Outstanding

4,196,182

Dividend Yield

PE Ratio

146.27

Earnings Per Share (EPS)

0.07

Revenue

163k

Net Profit

281k

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and compos... Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Show more

Sector

Surgical,med Instr,apparatus

Industry

Misc Health & Allied Svc,nec

Website

www.daxor.com

Headquarters

Oak Ridge, New Jersey, USA

Founded

2010

Daxor Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DXR. The last closing price for Daxor was $9.88. Over the last year, Daxor shares have traded in a share price range of $ 7.11 to $ 13.30.

Daxor currently has 4,196,182 shares outstanding. The market capitalization of Daxor is $41.12 million. Daxor has a price to earnings ratio (PE ratio) of 146.27.

New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion

Data Presented at the American College of Cardiology Scientific Sessions; Research Letter Published in the Prestigious American Heart Journal Oak Ridge, TN, April 16, 2024 (GLOBE NEWSWIRE...

DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)

The Premier Event for Cardiovascular Industry Leaders and Clinicians Oak Ridge, TN, April 15, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...

Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital

450-Bed Hospital Purchases BVA-100™ Blood Volume Analyzer to Launch Heart Failure Program Oak Ridge, TN, April 10, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in...

Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24

Oak Ridge, TN, April 01, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the American...

Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics

Expected to Improve Margins and Increase Revenue Streams Oak Ridge, TN, March 25, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...

Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024

Oak Ridge, TN, March 22, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces an investor call to be held on Monday...

Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023

Strong Start to 2024 with Unaudited Revenue Climbing 229.1% in First Two Months of 2024 YoY Oak Ridge, TN, March 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader...

Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base

Oak Ridge, TN, March 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today announces the expansion of blood volume analysis...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	9.8	9.95	9.51	5864	9.82540475	CS
4	0.82	9.13140311804	8.98	9.95	8.98	3656	9.71118889	CS
12	1.3	15.2941176471	8.5	9.95	7.19	2831	8.88415697	CS
26	1.89	23.8938053097	7.91	10.04	7.11	2899	8.88261678	CS
52	-1.8	-15.5172413793	11.6	13.3	7.11	3877	9.41849579	CS
156	-1.17	-10.6654512306	10.97	14.55	7.11	4109	10.21537895	CS
260	-1.17	-10.6654512306	10.97	14.55	7.11	4109	10.21537895	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OMHOhmyhome Ltd	$ 0.8189 (45.20%)	4.18M
WRAPWrap Technologies Inc	$ 1.85 (9.47%)	6.83k
SGBXSafe and Green Holdings Corporation	$ 6.06 (9.39%)	395.94k
DGHIDigihost Technology Inc	$ 1.73 (8.81%)	2.56k
PWMPrestige Wealth Inc	$ 1.12 (8.21%)	537
AFIBAcutus Medical Inc	$ 0.097 (-32.96%)	1.44M
MMATMeta Materials Inc	$ 2.40 (-28.36%)	180.66k
GVVisionary Holdings Inc	$ 0.2204 (-18.37%)	122.91k
DRRXDurect Corp	$ 1.03 (-11.21%)	1.76k
GRTXGalera Therapeutics Inc	$ 0.1673 (-10.05%)	798.18k
CMCSAComcast Corporation	$ 38.75 (0.16%)	6.76M
OMHOhmyhome Ltd	$ 0.8189 (45.20%)	4.18M
FFIEFaraday Future Intelligent Electric Inc	$ 0.0401 (-1.96%)	3.82M
GWAVGreenwave Technology Solutions Inc	$ 0.0604 (-6.50%)	3.11M
SQQQProShares UltraPro Short QQQ	$ 11.03 (-0.45%)	2.73M